Lyphomed, Inc. Report issue

For profit
Founded: Des Plaines IL United States (1969)
Status: Acquired by Fujisawa (1990) → now Leo Pharma (2015)

Organization Overview

First Clinical Trial
1999
NCT00002292
First Marketed Drug
1977
lidocaine (xylocaine)
First NDA Approval
None
Last Known Activity
1999

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Lyphomed | LyphoMed | LYPHOMED

Active Ingredients

Marketed Drugs (8)

aminophylline (aminophyllin) (1981)

cyanocobalamin (berocca) (1979)

dexamethasone (1981)

diphenhydramine (benadryl) (1981)

dopamine (intropin)

lidocaine (xylocaine) (1977)

metoclopramide (reglan) (1986)

urea (1981)

Drugs in Other Trials (1)

pentamidine (pentam) (2 trials)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 2
  • # of Trial APIs: 1